Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-007666

Co-Chief Executive Officer sold 7,715 shares at $11.09 ($85,596)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2026-01-06 Sale −7,715 $11.09 $85,596 3,317,632 D
Open-market sales · 7,715 sh · avg $11.09 · $85,596
Loading xslF345X05/ownership.xml…